Despite the relation between Gal-3 and cardiovascular events in CAD patients [43], [44], combination data between Gal-3 (LGALS-3 rs4652) gene variant and its gene expression levels with the risk of CAD in T2DM patients among an Egyptian population have not been published to date. Here, LGALS3 is linked to type 2 diabetes mellitus.